Loading the security page…
The series is stated in the current share scale after splits; dividends are not included in the price
BrightSpring provides healthcare at home and supplies medicines to people who cannot get to a pharmacy.
The company serves the elderly, people with disabilities and patients needing long-term care: nurse visits at home, help with daily living, behavioural therapy. The payer is almost always governmental, and the reimbursement rate decides whether a service is profitable.
The second and fast-growing part is a pharmacy delivering specialty medicines, including expensive oncology and weight-loss drugs. Turnover there is enormous and the mark-up small, so gross profit is the figure to watch rather than revenue. Risks: government programme reimbursement, labour costs and staff availability. The company pays no dividend.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
The issuer has several share classes — market cap covers the whole company.
BrightSpring Health Services, Inc. (BTSG) is a company in the Health care sector; its shares trade on Nasdaq.
The price of BrightSpring Health Services, Inc. (BTSG) on November 2, 2026 is 65.72 $, −1.75 % on the day. Over 52 weeks the stock traded between 29.01 $ and 73.75 $; the price now sits 82 % of the way up that range. Over the past year the price changed by +106.69 %. The P/E ratio is 35.43, which is above the sector median (24.61). Market capitalization is 12.97 billion $, rank 2 among 7 stocks of the same industry with a known capitalization.
BrightSpring Health Services, Inc. trades on Nasdaq under the ticker BTSG. The company belongs to the Health care sector. The trading history on this page starts on 26 January 2024.
Over the past 52 weeks BTSG has traded between 29.01 $ and 73.75 $. As of 2 November 2026 the price stood 71.21 % of the way from the 52-week low to the high.
Over one year BTSG shares rose 106.69 %; over six months they rose 28.77 %. Volatility over 90 days is 50.58 %. Dividends are not included: this is price change only, as of 2 November 2026.
BTSG trades at a price-to-earnings ratio of 35.4, above the sector median of 24.6. Price to sales is 0.9, below the sector median of 3.6. Price to book is 6.3, above the sector median of 2.5. Calculated from reports for the period ending 30 June 2026.
BrightSpring Health Services, Inc. reported revenue of 14.4B $ and net income of 366M $ over the last four quarters. Net margin is 2.55 %. Revenue changed by +26.35 % year over year. Earnings per share are 1.65 $. Market capitalisation is 13.0B $.
BTSG has a return on equity of 17.86 %, above the sector median of −40.58 %. Return on assets is 6.11 %, above the sector median of −30.08 %. Operating margin is 3.12 %, above the sector median of −20.96 %.